Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Capital Expenditures (2018 - 2025)

Bally's (BALY) has disclosed Capital Expenditures for 8 consecutive years, with -$53.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures fell 140.54% to -$53.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$109.4 million, a 156.02% decrease, with the full-year FY2024 number at $20.3 million, changed N/A from a year prior.
  • Capital Expenditures was -$53.3 million for Q3 2025 at Bally's, down from $57.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $146.7 million in Q3 2023 to a low of -$135.5 million in Q4 2024.
  • A 5-year average of $25.2 million and a median of $24.8 million in 2024 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 4270.88% in 2021, then tumbled 378.81% in 2022.
  • Bally's' Capital Expenditures stood at $16.2 million in 2021, then crashed by 378.81% to -$45.1 million in 2022, then soared by 425.1% to $146.7 million in 2023, then plummeted by 192.38% to -$135.5 million in 2024, then skyrocketed by 60.64% to -$53.3 million in 2025.
  • Per Business Quant, the three most recent readings for BALY's Capital Expenditures are -$53.3 million (Q3 2025), $57.8 million (Q2 2025), and $21.6 million (Q1 2025).